DeutschNewstral
Article
Chicago Tribune on 2016-10-11 22:37
Abbott says St. Jude heart device problem won't affect sale
Related news
St. Jude device gives early warning on heart failureStar Tribune- FDA warns Abbott on heart device battery woes, cybersecurity risksChicago Tribune
- St. Jude Medical to buy Calif. heart-device firm for $3.4BStar Tribune
Muddy Waters shorts St. Jude on heart device hacking fears; shares dropReuters
St. Jude Medical to Expand Heart-Device Businesswsj.com
St. Jude sues Muddy Waters, MedSec over heart device allegationsThe Globe and Mail
Abbott says it's not buying St. Judebizjournals.com- FDA approves St. Jude Medical Parkinson's devicebizjournals.com
- Abbott finalizes acquisition of St. Jude, boosting cardiovascular businessChicago Tribune
- St. Jude Medical to pay $27 million in Justice Dept. settlement on heart devicesStar Tribune
- New St. Jude device treats chronic pain using an iPodStar Tribune
- Heart device maker St. Jude to buy Thoratec for $3.4 billionReuters
- Abbott to buy Twin Cities heart device company Tendyne for at least $225Mbizjournals.com
- Old versions of heart device implanted after battery problem knownStar Tribune
- FDA says St. Jude heart devices vulnerable to hackingStar Tribune
- TInestor warns of hacking risk for St. Jude Medical heart devicestwincities.com
New lifesaving heart device19 Action News- FAbbott denies $25bn bid for St Judeft.com
- LCardiac Resynchronization Therapy Device Market Size and Analysis | Leading Keyplayers – Abbott Laboratories, Omron, Advanced Cardiac Therapeutics, Carmat, Volcano, AtriCure, Berlin Heart, Biosensors International, Biotronik, Cordis,liverpoolstudentmedia.com
St. Jude Medical, LLC v. Snyders Heart Valve LLC (Fed. Cir. 2020)jdsupra.com